Completed
Phase 3
Age: 30Years - 69Years
All Genders
ID00000491
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-03-25
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine whether the daily administration of 1 gm of aspirin to individuals with a documented myocardial infarction would result in a significant reduction in mortality over a three year period.
CONDITIONS
Official Title
Aspirin-Myocardial Infarction Study (AMIS)
Who Can Participate
Age: 30Years - 69Years
All Genders
Eligibility Criteria
You may qualify if you...
Men and women, ages 30 to 69. Had a documented myocardial infarction.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
A randomized, controlled trial of aspirin in persons recovered from myocardial infarction.
https://pubmed.ncbi.nlm.nih.gov/6985998The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
https://pubmed.ncbi.nlm.nih.gov/7438383Prognostic implications of diagnostic Q waves after myocardial infarction.
A G Wasserman, G B Bren, A M Ross...
https://pubmed.ncbi.nlm.nih.gov/7042113Timing, mechanism and clinical setting of witnessed deaths in postmyocardial infarction patients.
S Goldstein, L Friedman, R Hutchinson...
https://pubmed.ncbi.nlm.nih.gov/6423716Participation in a clinical trial: the patients' point of view.
M E Mattson, J D Curb, R McArdle
https://pubmed.ncbi.nlm.nih.gov/4006489Type A score (Jenkins Activity Survey) and risk of recurrent coronary heart disease in the aspirin myocardial infarction study.
R B Shekelle, M Gale, M Norusis
https://pubmed.ncbi.nlm.nih.gov/3895879Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study.
P H Frost, J Verter, D Miller
https://pubmed.ncbi.nlm.nih.gov/3591604Recruitment experience in the Aspirin Myocardial Infarction Study.
J A Schoenberger
https://pubmed.ncbi.nlm.nih.gov/3440392How blind was the patient blind in AMIS?
J Howard, A S Whittemore, J J Hoover...
https://pubmed.ncbi.nlm.nih.gov/7127995